{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:ropivacaine-hydrochloride-injection",
  "slug": "ropivacaine-hydrochloride-injection",
  "title": "FDA shortage status: Ropivacaine Hydrochloride Injection",
  "ingredient": "Ropivacaine Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "NAROPIN",
    "ROPIVACAINE HYDROCHLORIDE"
  ],
  "therapeutic_categories": [
    "Anesthesia"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "EPIDURAL",
    "INFILTRATION",
    "PERINEURAL"
  ],
  "package_count": 49,
  "packages": [
    {
      "package_ndc": "43066-027-10",
      "product_ndc": "43066-015",
      "company_name": "Caplin Steriles, Ltd.",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "06/10/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-015-10",
      "product_ndc": "43066-015",
      "company_name": "Caplin Steriles, Ltd.",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "06/10/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-019-10",
      "product_ndc": "43066-015",
      "company_name": "Caplin Steriles, Ltd.",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "06/10/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-023-10",
      "product_ndc": "43066-015",
      "company_name": "Caplin Steriles, Ltd.",
      "manufacturer_name": "Baxter Healthcare Corporation",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "06/10/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-200-10",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-201-20",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-195-20",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-196-99",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-197-20",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-198-30",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-199-20",
      "product_ndc": "55150-195",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "PERINEURAL"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-288-10",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-288-11",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-288-20",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-288-21",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-10",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-13",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-20",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-23",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-61",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-63",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-64",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-285-65",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65219-632-10",
      "product_ndc": "65219-632",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "FRESENIUS KABI USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "65219-632-20",
      "product_ndc": "65219-632",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "FRESENIUS KABI USA, LLC",
      "presentation": "Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-00",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-20",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-23",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-31",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-35",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-286-63",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-287-20",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-287-21",
      "product_ndc": "63323-285",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "PERINEURAL"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-671-66",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-671-67",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-671-82",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-671-87",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-652-82",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "25021-652-87",
      "product_ndc": "25021-652",
      "company_name": "InfoRLife SA",
      "manufacturer_name": "Sagent Pharmaceuticals",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "03/27/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-067-10",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-067-25",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-061-10",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-061-25",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-062-10",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-062-25",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-063-25",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-064-01",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-064-10",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-064-25",
      "product_ndc": "70069-061",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INFILTRATION",
        "PERINEURAL"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "03/23/2018",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 33,
    "Limited Availability": 3,
    "Unavailable": 13
  },
  "initial_posting_date": "03/23/2018",
  "latest_source_update": "08/18/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}